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ABSTRACT 
Atherosclerosis is an inflammatory disease that can lead to clinical complications such as 
myocardial infarction and stroke. Expressed in both vascular and inflammatory cells, adhesion 
molecule CD44 can be cleaved from the cell surface, and soluble CD44 can be detected in 
blood. CD44 mediates many inflammatory events, some possibly critical for atherogenesis. 
However, the role of CD44 in atherosclerosis remains incompletely understood. Therefore, 
this thesis aimed to investigate the role of CD44 in atherogenesis. 
No association between soluble CD44 in serum and atherosclerosis, cardiovascular risk 
factors, and diabetes was determined, suggesting that soluble CD44 is not a suitable 
biomarker for atherosclerosis. In contrast, macrophages from patients with subclinical 
atherosclerosis showed enhanced levels of CD44 compared to healthy controls. CD44 
expression associated with increased interleukin-6 secretion, and macrophages treated with 
interleukin-6 exhibited augmented CD44 expression.  
To further examine the potential role of CD44 in atherosclerosis in vivo, low-density 
lipoprotein receptor-deficient (LDLr-/-) mice with or without CD44 expression were used. A 
bone marrow transplantation in LDLr-/- mice to obtain a mouse model with CD44-deficiency 
on bone marrow-derived cells was also performed. Surprisingly, and in contrast to published 
data on CD44 in apolipoprotein-deficient mice, CD44-deficiency in LDLr-/- mice resulted in 
no or very modest reduction of lesion development. However, both mast cells and T cells, two 
cell types involved in lesion instability and rupture, decreased due to CD44-deficiency in 
advanced lesions. Furthermore, altered CD44 expression may influence the extrinsic 
coagulation cascade and therefore may affect thrombus formation.  
Taken together, CD44 expression increased in macrophages from subjects with 
atherosclerosis. However, its soluble counterpart did not associate with subclinical 
atherosclerosis and did not hold promise as potential biomarker. Since altered CD44 
expression affects cell composition, it may contribute to lesion stability. 
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